Zanubrutinib Combined With BEAM for ASCT in Relapsed and Refractory DLBCL
Zanubrutinib Combined With BEAM for ASCT in Relapsed and Refractory DLBCL
Not yet recruiting · NCT06652165 · Registry updated 2024-10-22Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Zanubrutinib Combined With BEAM for ASCT in Relapsed and Refractory DLBCL | diffuse large B-cell lymphoma | Not yet recruiting | Phase 2 | 2024-10-22 | NCT06652165 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Ruijin Hospital | 454 |
0 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| No products are listed yet. | |||